Stifel Financial Corp Myriad Genetics Inc Transaction History

Stifel Financial Corp

  • $93.7 Billion
  • Q4 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
BUY
$13.91 - $21.32 $49,394 - $75,707
3,551 Added 22.62%
19,247 $368,000
Q3 2023

Nov 13, 2023
BUY
$15.99 - $23.22 $25,456 - $36,966
1,592 Added 11.29%
15,696 $251,000
Q2 2023

Aug 14, 2023
SELL
$17.56 - $23.76 $7,796 - $10,549
-444 Reduced 3.05%
14,104 $326,000
Q1 2023

May 12, 2023
BUY
$15.26 - $23.75 $30,397 - $47,310
1,992 Added 15.86%
14,548 $337,000
Q4 2022

Feb 13, 2023
SELL
$14.51 - $20.99 $72,520 - $104,908
-4,998 Reduced 28.47%
12,556 $182,000
Q3 2022

Nov 14, 2022
BUY
$18.21 - $27.88 $16,334 - $25,008
897 Added 5.39%
17,554 $335,000
Q2 2022

Aug 15, 2022
SELL
$16.45 - $25.88 $19,542 - $30,745
-1,188 Reduced 6.66%
16,657 $303,000
Q1 2022

May 13, 2022
SELL
$22.67 - $28.01 $22,125 - $27,337
-976 Reduced 5.19%
17,845 $450,000
Q4 2021

Feb 14, 2022
SELL
$24.13 - $32.63 $21,499 - $29,073
-891 Reduced 4.52%
18,821 $519,000
Q3 2021

Nov 15, 2021
SELL
$29.97 - $36.66 $2,787 - $3,409
-93 Reduced 0.47%
19,712 $637,000
Q2 2021

Aug 13, 2021
SELL
$25.39 - $32.61 $74,164 - $95,253
-2,921 Reduced 12.85%
19,805 $606,000
Q1 2021

May 14, 2021
BUY
$19.92 - $31.6 $137,667 - $218,387
6,911 Added 43.7%
22,726 $691,000
Q4 2020

Feb 12, 2021
BUY
$12.16 - $19.77 $14,251 - $23,170
1,172 Added 8.0%
15,815 $313,000
Q3 2020

Nov 16, 2020
SELL
$11.25 - $14.75 $136,170 - $178,534
-12,104 Reduced 45.25%
14,643 $190,000
Q2 2020

Aug 14, 2020
BUY
$10.69 - $16.49 $36,602 - $56,461
3,424 Added 14.68%
26,747 $303,000
Q1 2020

May 14, 2020
SELL
$9.78 - $29.53 $560,951 - $1.69 Million
-57,357 Reduced 71.09%
23,323 $332,000
Q4 2019

Feb 13, 2020
BUY
$20.93 - $35.1 $1.15 Million - $1.93 Million
55,054 Added 214.84%
80,680 $2.2 Million
Q3 2019

Nov 19, 2019
BUY
$22.08 - $47.08 $17,597 - $37,522
797 Added 3.21%
25,626 $733,000
Q3 2019

Nov 13, 2019
SELL
$22.08 - $47.08 $1.14 Million - $2.43 Million
-51,598 Reduced 67.51%
24,829 $710,000
Q2 2019

Aug 14, 2019
BUY
$22.67 - $35.0 $1.39 Million - $2.14 Million
61,276 Added 404.44%
76,427 $2.12 Million
Q1 2019

May 14, 2019
SELL
$26.93 - $34.7 $1.58 Million - $2.03 Million
-58,519 Reduced 79.43%
15,151 $504,000
Q4 2018

Feb 13, 2019
BUY
$27.23 - $45.56 $361,750 - $605,264
13,285 Added 22.0%
73,670 $2.14 Million
Q3 2018

Nov 13, 2018
BUY
$37.57 - $50.34 $124,619 - $166,977
3,317 Added 5.81%
60,385 $2.78 Million
Q2 2018

Aug 14, 2018
BUY
$27.75 - $40.17 $81,168 - $117,497
2,925 Added 5.4%
57,068 $2.13 Million
Q1 2018

May 11, 2018
BUY
$28.83 - $41.01 $18,307 - $26,041
635 Added 1.19%
54,143 $1.6 Million
Q4 2017

Feb 14, 2018
SELL
$28.45 - $37.14 $25,605 - $33,426
-900 Reduced 1.65%
53,508 $1.84 Million
Q3 2017

Nov 13, 2017
BUY
$24.01 - $36.2 $1.31 Million - $1.97 Million
54,408
54,408 $0

Others Institutions Holding MYGN

# of Institutions
227
Shares Held
92M
Call Options Held
297K
Put Options Held
20.7K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.2B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email